Dillenia indica
Dillenia indica · Accepted scientific name
Scientific literature: Very Sparse (13 studies) · ★☆☆☆☆
Dillenia indica is a versatile medicinal plant known for containing bioactive chemical compounds such as flavonoids, saponins, and tannins. Research has demonstrated that extracts from its leaves, flowers, and fruits exhibit significant antioxidant, antibacterial, antidiabetic, and anticancer activities. These therapeutic properties are often evaluated by studying their impact on conditions like oxidative stress, diabetes mellitus, and cancer. Various preparations, including aqueous ethanolic extracts (AEE), ethyl acetate extracts (EAE), emulgels, and buccal patches, are utilized to harness these biological benefits. Consequently, this plant serves as a promising natural source for developing targeted pharmaceutical interventions.
- Synonyms
- Dillenia Indica F. Elongata · Dillenia Elongata
- Common names
- Not available
- Family
- Dilleniaceae
- Distribution
- Southern America
- Plant Parts
- Fruit · Leaf
Classification
Common Names
Dillenia indica is a versatile plant known by a wide variety of regional and descriptive names. In Trinidad and Tobago, it is most commonly referred to as Chalta. On a global scale, the species is frequently called Elephant Apple due to the unique appearance of its fruit. Many people also simply identify the plant by its botanical name, calling it Dillenia. Depending on the local dialect or spelling preference, you may even encounter variations such as dilênia.
Sources: Catalogue of Life (COL)
Synonyms
Dillenia indica is a botanical subject frequently encountered under various taxonomic designations in scientific literature. Within certain botanical records, the plant is recognized by the synonym Dillenia elongata. Furthermore, specific morphological variations are sometimes classified as Dillenia indica f. elongata. These nomenclatural shifts reflect the complexities involved in documenting the species' diverse forms. Understanding these relationships is essential for researchers aiming to maintain accurate and consistent botanical identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Dillenia indica belongs to the vast kingdom Plantae, representing a diverse group of living organisms. Within this kingdom, the species is classified under the class Equisetopsida. It further falls into the order Dilleniales, showcasing its specific evolutionary lineage. The plant is a member of the genus Dillenia, which distinguishes its unique structural characteristics. Finally, it is nested within the family Dilleniaceae, completing its formal botanical identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Dilleniales |
| Family | Dilleniaceae |
| Genus | Dillenia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Dillenia indica exhibits a broad geographical range that spans across diverse tropical and temperate regions. In Africa, this species is widely distributed throughout West-Central Tropical Africa and the Gulf of Guinea Islands. Its presence also extends into the Western Indian Ocean, where it can be found in the Comoros, Mauritius, and Réunion. Beyond the African continent, the plant reaches into the Asian-Temperate zone, specifically within South-Central China. This wide distribution highlights the plant's ability to thrive in various distinct ecological environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Dillenia indica is a self-supporting tree characterized by its sturdy and upright growth form. This species typically reaches a maximum height of 20 meters as it matures in its natural habitat. Its structural integrity allows it to stand firmly as a prominent feature of the forest canopy.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Dillenia indica, commonly known as the elephant apple, is a tropical fruit-bearing tree recognized for its extensive history in traditional medicine. Scientific research highlights its diverse pharmacological profile, most notably its potent antioxidant activity driven by bioactive compounds like flavonoids and tannins. The plant also demonstrates significant antidiabetic potential, offering promising avenues for managing metabolic disorders and associated complications. Furthermore, its antimicrobial and antibacterial properties make it a valuable natural agent for combating various pathogenic infections. Beyond these uses, preclinical studies have even identified anticancer capabilities, showing that its extracts can inhibit the proliferation of several cancer cell types.
Compounds
Dillenia indica, commonly known as the elephant apple, is a tropical fruit-bearing tree valued for its diverse array of bioactive phytochemicals. Research indicates that the plant contains significant amounts of flavonoids and tannins, which serve as potent antioxidants to combat oxidative stress. Its medicinal profile is further enhanced by the presence of saponins, which contribute to its notable antimicrobial activities. Additionally, the fruit provides therapeutic benefits through essential constituents such as ascorbic acid and betulinic acid. Together, these compounds underpin the plant's potential to treat various conditions, ranging from metabolic disorders to skin inflammation.
Conditions
Dillenia indica possesses potent antioxidant properties, largely driven by bioactive compounds like flavonoids and tannins that effectively scavenge free radicals. These antioxidant capabilities help the plant reduce oxidative stress, a mechanism that is critical in managing metabolic disorders and neurodegenerative diseases. Furthermore, the plant has demonstrated significant potential in treating cancer by inhibiting cell proliferation and inducing apoptosis in various cancer types, such as breast, colorectal, and liver cancers. Regarding metabolic health, Dillenia indica is utilized in traditional medicine to treat diabetes mellitus and can help suppress hyperglycemia by upregulating GLUT4 protein expression. In preclinical models, the plant also works to attenuate apoptosis in vital tissues, such as the liver and kidney, by modulating key apoptotic proteins.
Preparations
Dillenia indica is prepared as various extracts, including an aqueous ethanolic extract (AEE) and an ethyl acetate extract (EAE), to evaluate its healing effects on skin wounds. These specific extracts, such as the AEE and EAE, are standardized to betulinic acid for medicinal research. Beyond simple extracts, the plant is also prepared as specialized dosage forms like buccal patches to provide localized therapeutic delivery. Additionally, Dillenia indica is prepared as an emulgel to combine the benefits of emulsions and gels for improved drug stability. These diverse preparations highlight the plant's significant potential in pharmaceutical development and disease treatment.
Parts used
Dillenia indica is a medicinal tree of the Dilleniaceae family that possesses various parts utilized for diverse therapeutic applications. Research has highlighted the significant health benefits of its fruit, particularly regarding its potential antidiabetic properties and its ability to aid in healing psoriasis-like wounds. The leaf of this plant also serves as a vital component in medicinal studies, demonstrating cytotoxic activity against certain cancer cell lines and providing a host for beneficial endophytic fungi. Additionally, the flower of the species is a valuable resource, even being used in the biosynthesis of silver nanoparticles for antibacterial and antioxidant purposes. Together, these different parts of Dillenia indica contribute to its growing importance in pharmacological research and traditional medicine.